PR84435

SEOUL, South Korea, June 18, 2020 /PRNewswire=KYODO JBN/--

Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-Keun,

Lee) entered into a Supply Agreement, where Yuyu Pharma will export COVID-19

Test Kits to the Global Market. Leveraging Yuyu Pharma's global network, the

company is in talks with several healthcare providers and leading hospitals to

export the COVID-19 kits.

Photo - https://photos.prnasia.com/prnh/20200617/2833596-1-a

STANDARD(TM) M nCoV Real-Time Detection kit

Photo - https://photos.prnasia.com/prnh/20200617/2833596-1-b

Yuyu Pharma Will Export COVID-19 Test Kits to the Global Market

US FDA gave Emergency Use Authorization (EUA) to STANDARD M nCoV Real-Time

Detection Kit made by SD BIOSENSOR back in April 23, 2020. With the EUA, SD

BIOSENSOR has the authority to supply STANDARD M nCoV Real-Time Detection Kit

across the US. STANDARD M nCoV Real-Time Detection Kit is used for rapid

identification and detection of novel coronavirus (2019-nCoV) nucleic acids in

human nasopharyngeal swabs and throat swab samples. This is RT-PCR test that

amplifies and diagnoses a specific gene sequence of COVID-19.

Federal Emergency Management Agency (FEMA), an agency within the US Department

of Homeland Security, has already purchased $5.2 million USD of SD Biosensor's

test kits back in April 2020.

Hyo-Keun, Lee CEO of SD BIOSENSOR said that "We have been providing quality

kits since 2010. Our HIV, Malaria and Syphilis test kits are already on the

World Health Organization (WHO) list of prequalified in vitro diagnostic

products. And we are proud to know that our COVID-19 kits will help facilitate

in the fight against the spread of the coronavirus and possibly save lives. We

will continue to provide quality products to help improve the health of all

people around the world"

Robert Yu, CEO of Yuyu Pharma, said that "The partnership with SD BIOSENSOR

will help provide much needed COVID-19 Kits to medical professionals. We hope

our efforts will contribute in the fight against the coronavirus."

About Yuyu Pharma

Yuyu Pharma (KRX: 000220) is a pharmaceutical company founded in 1941. The

company manufactures, distributes, and does marketing for pharmaceutical

products, medical devices, and medical foods in South Korea and Southeast Asia.

Currently, Yuyu Pharma is focusing on developing new drugs for treating

enlarged prostates and dry eye syndrome.

Yuyu pharma contact Point

Global Sales Team

Franklin Park / sehoonpark@yuyu.co.kr

SOURCE  Yuyu Pharma

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=365554

   Caption: STANDARD(TM) M nCoV Real-Time Detection kit

   Link: http://asianetnews.net/view-attachment?attach-id=365556

   Caption: Yuyu Pharma Will Export COVID-19 Test Kits to the Global Market